Article
Comprehensive characterization of PTEN mutational profile in a series of 34,129 colorectal cancers.
Nature communications - 25 Mar 2022
Serebriiskii Ilya G, Pavlov Valery, Tricarico Rossella, Andrianov Grigorii, Nicolas Emmanuelle, Parker Mitchell I, Newberg Justin, Frampton Garrett, Meyer Joshua E, Golemis Erica A
Abstract excerpt
Loss of expression or activity of the tumor suppressor PTEN acts similarly to an activating mutation in the oncogene PIK3CA in elevating intracellular levels of phosphatidylinositol (3,4,5)-trisphosphate (PIP3), inducing signaling by AKT and other pro-tumorigenic signaling proteins. Here, we analyze sequence data for 34,129 colorectal cancer (CRC) patients, capturing 3,434 PTEN mutations. We identify specific...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
